An update from Solara Active Pharma Sciences Ltd. ( ($IN:SOLARA) ) is now available. Solara Active Pharma Sciences Limited announced the ...
The Active Pharmaceutical Ingredient (API) Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated between 2025 and 2034. As industries ...
C2 PHARMA receives CEP approval from EDQM for oxybuprocaine hydrochloride: Cork, Ireland Thursday, January 30, 2025, 10:00 Hrs [IST] C2 PHARMA, the global leader in manufacturing ...